Hyderabad (Telangana) [India], April 26 (ANI/PNN): Optimus Pharma has announced today that it has received DCGI approval for its Anti-Parkinson's drug Safinamide. Safinamide is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease (PD) experiencing "off
Washington D.C. [USA], Sep 29 (ANI): U.S. researchers have recently discovered that a drug - carbidopa - used to treat Parkinson's disease significantly displayed